文献速递系统性红斑狼疮

依据纵向基因表达将系统性红斑狼疮患者分层为三组疾病活动进展

Stratification of Systemic Lupus Erythematosus Patients Into Three Groups of Disease Activity Progression According to Longitudinal Gene Expression.
PubMed 文献 · Arthritis Rheumatol · 2018-10-27

研究采用基于聚类的策略,依据疾病活动评分与纵向基因表达信息的相关性对系统性红斑狼疮(SLE)患者进行分层,在一个儿童和一个成人两个独立患者集中均观察到清晰的3个疾病聚类,且不受治疗、种族或其他偏倚来源影响。其中两个聚类分别表现为中性粒细胞百分比与疾病活动进展相关、淋巴细胞百分比与疾病活动进展相关,第三个聚类中中性粒细胞百分比与疾病活动相关性较低且功能上更为异质。中性粒细胞驱动的聚类患者发生增殖性肾炎的风险增加。

要点

  • SLE患者可依据纵向基因表达与疾病活动评分的相关性分为3个疾病进展机制不同的亚组。
  • 两个聚类分别表现为中性粒细胞百分比或淋巴细胞百分比与疾病活动进展相关。
  • 中性粒细胞驱动的聚类患者发生增殖性肾炎的风险增加。

核心结论

  • SLE患者可被分层为3个疾病进展机制不同且临床上有差异的亚组。
  • 该结果对治疗选择、临床试验设计、疾病病因理解及严重肾小球肾炎预测具有重要意义。

研究设计与样本

  • 采用基于聚类的方法,依据疾病活动评分与纵向基因表达信息之间的相关性对SLE患者进行分层。
  • 聚类稳健性通过bootstrap方法评估,并对聚类进行临床和功能特征描述。
  • 在一个儿童患者集和一个成人患者集两个独立患者集中观察到清晰的3个疾病聚类划分。

主要发现

  • 在两个独立患者集中均观察到清晰的3个不同疾病聚类,且不受治疗、种族或其他偏倚来源影响。
  • 两个聚类分别分化为中性粒细胞百分比与疾病活动进展相关的一组和淋巴细胞百分比与疾病活动进展相关的一组。
  • 第三个聚类中中性粒细胞百分比与疾病活动的相关性较低,功能上更为异质。
  • 中性粒细胞驱动的聚类患者发生增殖性肾炎的风险增加。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The highly heterogeneous clinical presentation of systemic lupus erythematosus (SLE) is characterized by the unpredictable occurrence of disease flares and organ damage. Attempts to stratify lupus patients have been limited to classification based on clinical information, leading to unsuccessful clinical trials and controversial research results. This study was undertaken to develop and validate a robust method to stratify patients with lupus according to longitudinal disease activity and whole-genome gene expression data in order to establish subgroups of patients who share disease progression mechanisms. METHODS: We used a cluster-based approach to stratify SLE patients based on the correlation between disease activity scores and longitudinal gene expression information. Clustering robustness was evaluated by the bootstrap method, and the clusters were characterized in terms of clinical and functional features. RESULTS: We observed a clear partition into 3 different disease clusters in 2 independent sets of patients, one pediatric and one adult, which was not influenced by treatment, race, or other source of bias. Two of the clusters differentiated into a group showing a correlation between the percentage of neutrophils and disease activity progression and a group showing a correlation between the percentage of lymphocytes and disease activity progression. The third cluster, in which the percentage of neutrophils correlated to a lesser degree with disease activity, was functionally more heterogeneous. Patients in the neutrophil-driven clusters had an increased risk of developing proliferative nephritis. CONCLUSION: Our findings indicate that SLE patients can be stratified into 3 subgroups of patients who show different mechanisms of disease progression and are clinically differentiated. Our results have important implications for treatment options, the design of clinical trials, our understanding of the etiology of the disease, and the prediction of severe glomerulonephritis.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Toro-Domínguez D, Martorell-Marugán J, Goldman D, et al. Stratification of Systemic Lupus Erythematosus Patients Into Three Groups of Disease Activity Progression According to Longitudinal Gene Expression. Arthritis Rheumatol. 2018. PMID: 29938934. doi:10.1002/art.40653

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。